EMA/511051/2020 
Lumark 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification
Decision 
Information 
1 issued on 
Issued 2 / 
affected 3 
amended 
on 
PSUSA/10391
Periodic Safety Update EU Single assessment - 
23/07/2020 
17/09/2020 
SmPC and PL 
Refer to Scientific conclusions and grounds recommending 
/201912 
lutetium (177Lu) chloride 
the variation to terms of the Marketing Authorisation(s)’ for 
PSUSA/10391/201912. 
R/0014 
Renewal of the marketing authorisation. 
27/02/2020 
23/04/2020 
SmPC, Annex 
Based on the review of data on quality, safety and efficacy, 
II, Labelling 
the CHMP considered that the benefit-risk balance of 
and PL 
Lumark in the approved indication remains favourable and 
therefore recommended the renewal of the marketing 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
  
 
 
 
 
 
 
IB/0015 
B.II.e.1.z - Change in immediate packaging of the 
28/11/2019 
n/a 
finished product - Other variation 
authorisation with unlimited validity. 
PSUSA/10391
Periodic Safety Update EU Single assessment - 
25/07/2019 
19/09/2019 
SmPC and PL 
Refer to Scientific conclusions and grounds recommending 
/201812 
lutetium (177Lu) chloride 
the variation to terms of the Marketing Authorisation(s)’ for 
PSUSA/10391/201812. 
IB/0012 
C.I.11.z - Introduction of, or change(s) to, the 
03/04/2019 
n/a 
obligations and conditions of a marketing 
authorisation, including the RMP - Other variation 
PSUSA/10391
Periodic Safety Update EU Single assessment - 
31/01/2019 
02/04/2019 
SmPC and PL 
Refer to Scientific conclusions and grounds recommending 
/201806 
lutetium (177Lu) chloride 
the variation to terms of the Marketing Authorisation(s)’ for 
PSUSA/10391/201806. 
N/0010 
Minor change in labelling or package leaflet not 
02/10/2018 
02/04/2019 
Labelling 
connected with the SPC (Art. 61.3 Notification) 
PSUSA/10391
Periodic Safety Update EU Single assessment - 
26/07/2018 
20/09/2018 
SmPC and PL 
Refer to Scientific conclusions and grounds recommending 
/201712 
lutetium (177Lu) chloride 
the variation to terms of the Marketing Authorisation(s)’ for 
PSUSA/10391/201712. 
IB/0009/G 
This was an application for a group of variations. 
21/08/2018 
n/a 
B.I.a.1.z - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - Other 
variation 
B.I.b.1.z - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Other variation 
B.II.c.1.z - Change in the specification parameters 
and/or limits of an excipient - Other variation 
Lumark  
EMA/511051/2020 
Page 2/3 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PSUSA/10391
Periodic Safety Update EU Single assessment - 
25/01/2018 
04/04/2018 
Refer to Scientific conclusions and grounds recommending 
/201706 
lutetium (177Lu) chloride 
the variation to terms of the Marketing Authorisation(s)’ for 
PSUSA/10391/201706. 
IB/0007 
C.I.11.z - Introduction of, or change(s) to, the 
09/02/2018 
n/a 
obligations and conditions of a marketing 
authorisation, including the RMP - Other variation 
PSUSA/10391
Periodic Safety Update EU Single assessment - 
20/07/2017 
18/09/2017 
SmPC and PL 
Refer to Scientific conclusions and grounds recommending 
/201612 
lutetium (177Lu) chloride 
the variation to terms of the Marketing Authorisation(s)’ for 
PSUSA/10391/201612. 
PSUSA/10391
Periodic Safety Update EU Single assessment - 
12/01/2017 
n/a 
PRAC Recommendation - maintenance 
/201606 
lutetium (177Lu) chloride 
IAIN/0004 
A.5.a - Administrative change - Change in the name 
11/01/2017 
18/09/2017 
Annex II, 
and/or address of a manufacturer/importer 
responsible for batch release 
Labelling and 
PL 
T/0002 
Transfer of Marketing Authorisation 
03/08/2016 
22/08/2016 
SmPC, 
Labelling and 
PL 
PSUSA/10391
Periodic Safety Update EU Single assessment - 
07/07/2016 
n/a 
PRAC Recommendation - maintenance 
/201512 
lutetium (177Lu) chloride 
Lumark  
EMA/511051/2020 
Page 3/3 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
